Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis

Not yet recruitingOBSERVATIONAL
Enrollment

328

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
RRMS
Interventions
OTHER

Modified Yishen Daluo Yin formula

The specific application of the modified Yishen Daluo Yin formula, including the starting point, dosage, and duration of treatment, should be determined based on medical advice, the patient's condition, and their individual preferences.

All Listed Sponsors
collaborator

The Second Hospital of Hebei Medical University

OTHER

collaborator

First Affiliated Hospital of Jinan University

OTHER

collaborator

Chinese PLA General Hospital

OTHER

lead

Ying Gao

OTHER